Shares in Tandem Diabetes Care (NSDQ:TNDM) have risen in after-hours trading today after the diabetes-focused device maker posted first quarter earnings with significantly lifted 2019 sales guidance.
The San Diego-based company posted losses of approximately $23 million, or 40¢ per share, on sales of approximately $66 million for the three months ended March 31, seeing losses shrink 29.7% while sales grew 141.9% when compared to the same period during the previous year.
Read the whole story on our sister site, Drug Delivery Business